{"id":"doi:10.1073/pnas.1320318110","kind":"article","title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer","authors":["Christine Feig","James O. Jones","Matthew Kraman","Richard J. B. Wells","Andrew Deonarine","Derek S. Chan","Claire M. Connell","Edward W. Roberts","Qi Zhao","Otávia L. Caballero","Sarah Amalia Teichmann","Tobias Janowitz","Duncan Ian Jodrell","David Arthur Tuveson","Douglas T. Fearon"],"author_count":15,"year":2013,"published":"2013-11-25","venue":"Proceedings of the National Academy of Sciences","cited_by":2098,"doi":"10.1073/pnas.1320318110","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1073/pnas.1320318110","archive_url":"https://space-kitty.com/papers/doi:10.1073/pnas.1320318110","updated":null,"pmid":"24277834","pmcid":null,"openalex_id":"W2086834665","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Cancer Immunotherapy and Biomarkers"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"cancer-immunotherapy","title":"Cancer Immunotherapy: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/cancer-immunotherapy"}]}